183 related articles for article (PubMed ID: 36809483)
1. Artificial intelligence-assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies.
Eloy C; Marques A; Pinto J; Pinheiro J; Campelos S; Curado M; Vale J; Polónia A
Virchows Arch; 2023 Mar; 482(3):595-604. PubMed ID: 36809483
[TBL] [Abstract][Full Text] [Related]
2. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
Pantanowitz L; Quiroga-Garza GM; Bien L; Heled R; Laifenfeld D; Linhart C; Sandbank J; Albrecht Shach A; Shalev V; Vecsler M; Michelow P; Hazelhurst S; Dhir R
Lancet Digit Health; 2020 Aug; 2(8):e407-e416. PubMed ID: 33328045
[TBL] [Abstract][Full Text] [Related]
3. Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies.
Raciti P; Sue J; Ceballos R; Godrich R; Kunz JD; Kapur S; Reuter V; Grady L; Kanan C; Klimstra DS; Fuchs TJ
Mod Pathol; 2020 Oct; 33(10):2058-2066. PubMed ID: 32393768
[TBL] [Abstract][Full Text] [Related]
4. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.
Perincheri S; Levi AW; Celli R; Gershkovich P; Rimm D; Morrow JS; Rothrock B; Raciti P; Klimstra D; Sinard J
Mod Pathol; 2021 Aug; 34(8):1588-1595. PubMed ID: 33782551
[TBL] [Abstract][Full Text] [Related]
5. Independent real-world application of a clinical-grade automated prostate cancer detection system.
da Silva LM; Pereira EM; Salles PG; Godrich R; Ceballos R; Kunz JD; Casson A; Viret J; Chandarlapaty S; Ferreira CG; Ferrari B; Rothrock B; Raciti P; Reuter V; Dogdas B; DeMuth G; Sue J; Kanan C; Grady L; Fuchs TJ; Reis-Filho JS
J Pathol; 2021 Jun; 254(2):147-158. PubMed ID: 33904171
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Use of Combined Artificial Intelligence and Pathologist Assessment to Review and Grade Prostate Biopsies.
Steiner DF; Nagpal K; Sayres R; Foote DJ; Wedin BD; Pearce A; Cai CJ; Winter SR; Symonds M; Yatziv L; Kapishnikov A; Brown T; Flament-Auvigne I; Tan F; Stumpe MC; Jiang PP; Liu Y; Chen PC; Corrado GS; Terry M; Mermel CH
JAMA Netw Open; 2020 Nov; 3(11):e2023267. PubMed ID: 33180129
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
[TBL] [Abstract][Full Text] [Related]
8. Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection.
Raciti P; Sue J; Retamero JA; Ceballos R; Godrich R; Kunz JD; Casson A; Thiagarajan D; Ebrahimzadeh Z; Viret J; Lee D; Schüffler PJ; DeMuth G; Gulturk E; Kanan C; Rothrock B; Reis-Filho J; Klimstra DS; Reuter V; Fuchs TJ
Arch Pathol Lab Med; 2023 Oct; 147(10):1178-1185. PubMed ID: 36538386
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry in the workup of prostate biopsies: Frequency, variation and appropriateness of use among pathologists practicing at an academic center.
Al Diffalha S; Shaar M; Barkan GA; Wojcik EM; Picken MM; Pambuccian SE
Ann Diagn Pathol; 2017 Apr; 27():34-42. PubMed ID: 28325359
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence system shows performance at the level of uropathologists for the detection and grading of prostate cancer in core needle biopsy: an independent external validation study.
Jung M; Jin MS; Kim C; Lee C; Nikas IP; Park JH; Ryu HS
Mod Pathol; 2022 Oct; 35(10):1449-1457. PubMed ID: 35487950
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
[TBL] [Abstract][Full Text] [Related]
12. An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies.
Marginean F; Arvidsson I; Simoulis A; Christian Overgaard N; Åström K; Heyden A; Bjartell A; Krzyzanowska A
Eur Urol Focus; 2021 Sep; 7(5):995-1001. PubMed ID: 33303404
[TBL] [Abstract][Full Text] [Related]
13. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies.
Scattoni V; Roscigno M; Freschi M; Dehò F; Raber M; Briganti A; Fantini G; Nava L; Montorsi F; Rigatti P
Arch Ital Urol Androl; 2005 Mar; 77(1):31-6. PubMed ID: 15906787
[TBL] [Abstract][Full Text] [Related]
14. Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies.
Van der Kwast TH; Evans A; Lockwood G; Tkachuk D; Bostwick DG; Epstein JI; Humphrey PA; Montironi R; Van Leenders GJ; Pihl CG; Neetens I; Kujala PM; Laurila M; Mazerolles C; Bubendorf L; Finelli A; Watson K; Srigley J
Am J Surg Pathol; 2010 Feb; 34(2):169-77. PubMed ID: 20061936
[TBL] [Abstract][Full Text] [Related]
15. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
16. Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology.
Eminaga O; Abbas M; Kunder C; Tolkach Y; Han R; Brooks JD; Nolley R; Semjonow A; Boegemann M; West R; Long J; Fan RE; Bettendorf O
Sci Rep; 2024 Mar; 14(1):5284. PubMed ID: 38438436
[TBL] [Abstract][Full Text] [Related]
17. Patterns in immunohistochemical usage in extended core prostate biopsies: comparisons among genitourinary pathologists and nongenitourinary pathologists.
Plourde A; Gross A; Jiang Z; Owens CL
Arch Pathol Lab Med; 2013 Nov; 137(11):1630-4. PubMed ID: 24168501
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Pathologist on Prostate Biopsy Diagnosis and Immunohistochemical Stain Usage Within a Single Institution.
Shah MD; Parwani AV; Zynger DL
Am J Clin Pathol; 2017 Nov; 148(6):494-501. PubMed ID: 29165567
[TBL] [Abstract][Full Text] [Related]
19. Electronic expert consultation using digital still images for evaluation of atypical small acinar proliferations of the prostate: a comparison with immunohistochemistry.
Banihashemi A; Asgari M; Shooshtarizade T; Abolhasani M; Mireskandari M
Ann Diagn Pathol; 2014 Jun; 18(3):163-70. PubMed ID: 24767894
[TBL] [Abstract][Full Text] [Related]
20. Practice patterns of clinicians following isolated diagnoses of atypical small acinar proliferation on prostate biopsy specimens.
Fadare O; Wang S; Mariappan MR
Arch Pathol Lab Med; 2004 May; 128(5):557-60. PubMed ID: 15086303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
